Natus Medical Historical PE Ratio image   This NTUS PE ratio history page last updated 8/17/2022
Natus Medical Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q1 2022
5/5/2022
33.040.220.8837.5
Q4 2021
2/24/2022
24.000.471.8812.8
Q3 2021
11/4/2021
26.750.281.1223.9
Q2 2021
8/5/2021
26.970.291.1623.2
Q1 2021
5/6/2021
25.550.160.6439.9
Q4 2020
2/25/2021
26.040.391.5616.7
Q3 2020
10/29/2020
17.800.090.3649.4
Q2 2020
7/30/2020
21.10-0.13-0.52NA
Q1 2020
4/30/2020
24.990.040.16156.2
Q4 2019
2/6/2020
33.730.461.8418.3
Q3 2019
10/24/2019
32.520.361.4422.6
Q2 2019
7/25/2019
26.750.341.3619.7
Q1 2019
4/25/2019
25.190.090.3670.0
Q4 2018
2/13/2019
26.510.431.7215.4
Q3 2018
10/24/2018
29.510.401.6018.4
Q2 2018
7/25/2018
33.850.351.4024.2
Q1 2018
4/25/2018
33.500.240.9634.9
Q4 2017
2/7/2018
30.800.421.6818.3
Q3 2017
10/25/2017
39.600.401.6024.8
Q2 2017
7/26/2017
36.250.341.3626.7
Q1 2017
4/26/2017
36.200.301.2030.2
Q4 2016
2/1/2017
36.600.512.0417.9
Q3 2016
10/19/2016
42.000.391.5626.9
Q2 2016
7/20/2016
39.470.391.5625.3
Q1 2016
4/20/2016
33.200.341.3624.4
Q4 2015
1/27/2016
37.150.512.0418.2
Q3 2015
10/21/2015
45.000.391.5628.8
Q2 2015
7/22/2015
46.330.341.3634.1
Q1 2015
4/22/2015
41.640.311.2433.6
Q4 2014
1/28/2015
37.980.401.6023.7
Q3 2014
10/22/2014
32.800.331.3224.8
Q2 2014
7/23/2014
26.660.281.1223.8
Q1 2014
4/23/2014
26.080.190.7634.3
Q4 2013
1/29/2014
25.850.371.4817.5
Q3 2013
10/24/2013
19.310.301.2016.1
Q2 2013
8/1/2013
13.640.210.8416.2
Q1 2013
4/26/2013
12.970.110.4429.5
Q4 2012
2/28/2013
12.700.291.1610.9
Q3 2012
11/7/2012
11.420.150.6019.0
Q2 2012
7/26/2012
NA0.120.48NA
Q1 2012
4/26/2012
11.400.070.2840.7
Natus Medical PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2022
5/5/2022
33.040.221.2626.2
Q4 2021
2/24/2022
24.000.471.2020.0
Q3 2021
11/4/2021
26.750.281.1223.9
Q2 2021
8/5/2021
26.970.290.9329.0
Q1 2021
5/6/2021
25.550.160.5150.1
Q4 2020
2/25/2021
26.040.390.3966.8
Q3 2020
10/29/2020
17.800.090.4638.7
Q2 2020
7/30/2020
21.10-0.130.7328.9
Q1 2020
4/30/2020
24.990.041.2020.8
Q4 2019
2/6/2020
33.730.461.2527.0
Q3 2019
10/24/2019
32.520.361.2226.7
Q2 2019
7/25/2019
26.750.341.2621.2
Q1 2019
4/25/2019
25.190.091.2719.8
Q4 2018
2/13/2019
26.510.431.4218.7
Q3 2018
10/24/2018
29.510.401.4120.9
Q2 2018
7/25/2018
33.850.351.4124.0
Q1 2018
4/25/2018
33.500.241.4023.9
Q4 2017
2/7/2018
30.800.421.4621.1
Q3 2017
10/25/2017
39.600.401.5525.5
Q2 2017
7/26/2017
36.250.341.5423.5
Q1 2017
4/26/2017
36.200.301.5922.8
Q4 2016
2/1/2017
36.600.511.6322.5
Q3 2016
10/19/2016
42.000.391.6325.8
Q2 2016
7/20/2016
39.470.391.6324.2
Q1 2016
4/20/2016
33.200.341.5821.0
Q4 2015
1/27/2016
37.150.511.5524.0
Q3 2015
10/21/2015
45.000.391.4431.2
Q2 2015
7/22/2015
46.330.341.3833.6
Q1 2015
4/22/2015
41.640.311.3231.5
Q4 2014
1/28/2015
37.980.401.2031.6
Q3 2014
10/22/2014
32.800.331.1728.0
Q2 2014
7/23/2014
26.660.281.1423.4
Q1 2014
4/23/2014
26.080.191.0724.4
Q4 2013
1/29/2014
25.850.370.9926.1
Q3 2013
10/24/2013
19.310.300.9121.2
Q2 2013
8/1/2013
13.640.210.7617.9
Q1 2013
4/26/2013
12.970.110.6719.4
Q4 2012
2/28/2013
12.700.290.6320.2
Q3 2012
11/7/2012
11.420.15NANA
Q2 2012
7/26/2012
NA0.12NANA
Q1 2012
4/26/2012
11.400.07NANA
Quotes delayed 20 minutes

Email EnvelopeFree NTUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Natus Medical (NTUS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

NURO PE Ratio History
NUVA PE Ratio History
NUVL PE Ratio History
NUWE PE Ratio History
NVAX PE Ratio History
NVIV PE Ratio History
NVNO PE Ratio History
NVOS PE Ratio History
NVRO PE Ratio History
NVST PE Ratio History
How should the NTUS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Natus Medical. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this NTUS Historical PE Ratio page.

What is the average historical PE for NTUS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The NTUS historical PE ratio using the annualized quarterly earnings method works out to 29.5.

What is the average historical PE for NTUS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The NTUS historical PE ratio using the TTM earnings method works out to 26.5.

What is the average historical PE for NTUS based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The NTUS historical PE ratio using the annualized median TTM earnings method works out to 1.16.

On this page we presented the Natus Medical Historical PE Ratio information for Natus Medical' stock. The average NTUS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 29.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NTUS historical PE based on this TTM earnings result method is 26.5. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NTUS historical PE result, against the recent PE: when this page was posted on 7/21/2022, the most recent closing price for NTUS had been 32.96, and the most recent quarterly earnings result, annualized, was 0.88. Meanwhile, the most recent TTM earnings summed to 1.26. From these numbers, we calculate the recent NTUS PE on 7/21/2022 based on annualized quarterly EPS was 37.5. Based on NTUS's history, that recent PE is elevated relative to the historical average, with the recent PE 27.1% higher than the historical average PE across our data set for Natus Medical. Looking at the recent NTUS PE on 7/21/2022 based on TTM EPS, we calculate the ratio at 26.2. Based on NTUS's history, that recent PE is low relative to the historical average, with the recent PE 1.1% lower than the average PE across our Natus Medical data set with TTM EPS used in the calculation at each period.

Another interesting NTUS historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for NTUS, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for NTUS, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.22, 0.28, 0.29, and 0.47. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.28 and 0.29 — which gives us the median of 0.29. Basically the way to think about this 0.29 number is this: for the trailing four earnings reports, 0.29 marks the "middle ground" number where NTUS has reported a value higher than 0.29 half the time, and has reported a value lower than 0.29 half the time. Annualizing that median value then gets us to 1.16/share, which we use as the denominator in our next PE calculation. With 32.96 as the numerator (as of 7/21/2022), the calculation is then 32.96 / 1.16 = 28.4 as the NTUS PE ratio as of 7/21/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on NTUS or any other given stock, valuation analysis for NTUS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Natus Medical PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NTUS. Thanks for visiting, and the next time you need to research NTUS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: NAKD market cap history, AVIR Average Annual Return, NXEO shares outstanding history.

 

Natus Medical Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.